Impact BioMedical Inc [AMEX: IBO] stock went on a downward path that fall over -27.42% on Monday, amounting to a one-week price increase of more than 490.07%.
The market cap for the stock reached $41.40 million, with 11.50 million shares outstanding and 5.11 million shares in the current float. Compared to the average trading volume of 2.91M shares, IBO stock reached a trading volume of 6856782 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Impact BioMedical Inc [IBO]:
The Average True Range (ATR) for Impact BioMedical Inc is set at 0.74 The Price to Book ratio for the last quarter was 1.32, with the Price to Cash per share for the same quarter was set at 0.23.
IBO Stock Performance Analysis:
Impact BioMedical Inc [IBO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 490.07. With this latest performance, IBO shares gained by 69.81% in over the last four-week period, additionally plugging by 42.86% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IBO stock in for the last two-week period is set at 65.80, with the RSI for the last a single of trading hit 86.27, and the three-weeks RSI is set at 80.64 for Impact BioMedical Inc [IBO]. The present Moving Average for the last 50 days of trading for this stock 24.84, while it was recorded at 24.84 for the last single week of trading, and 24.11 for the last 200 days.
Insight into Impact BioMedical Inc Fundamentals:
Impact BioMedical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.79 and a Current Ratio set at 2.79.
Impact BioMedical Inc [IBO] Institutonal Ownership Details
There are presently around $1.89%, or 4.22%% of IBO stock, in the hands of institutional investors.
